It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2003.
2003 | Mumbai, Maharashtra, India | Under LiquidationNycomed Pharma Private Limited, a under liquidation private limited company, was established on 09 May 2003 in Mumbai, Maharashtra, India. Engaging in pharma contract r&d within the pharma sector, it holds CIN: U24239MH2003PTC148545. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹50.00 Cr and a paid-up capital of ₹9.72 Cr.
Its leadership includes Stefan Kollmann (Director), Felix Reutter (Director), Sham Shridhar Nikam (Director). Past directors included Suhas Ramchandra Tuljapurkar, Gerd Gorski, Stefan Kollmann. Its latest AGM occurred on 30 August 2013, with the balance sheet filed on 31 March 2013. It is based at 2/E Court Chambers 2Nd Floor,35, New Marine Lines, Mumbai, Maharashtra, 400020.
U24239MH2003PTC148545
148545
09 May 2003
₹50.00 Cr
₹9.72 Cr
Roc Mumbai
Unlisted
Under Liquidation
Explore comprehensive insights into Nycomed Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Stefan Kollmann | Director | 29 Mar 2013 | Current |
| Felix Reutter | Director | 29 Mar 2013 | Current |
| Sham Shridhar Nikam | Director | 29 Mar 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Mar 2012 | Past |
| Pramod Abcsdd | Director | 31 Mar 2013 | Past |
| Pramod Abcsdd | Additional Director | 30 Aug 2013 | Past |
| Pramod Abcsdd | Additional Director | 30 Aug 2013 | Past |
| Pramod Abcsdd | Director | 01 Sep 2008 | Past |
| Pramod Abcsdd | Director | 31 Mar 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Nycomed Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Nycomed Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Nycomed Pharma has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nycomed Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nycomed Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Nycomed Pharma Private Limited last Annual general meeting of members was held on 30 Aug 2013 as per latest MCA records. was completed.
The activity Nycomed Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Mumbai. was completed.
Progress on Stefan Kollmann was appointed as a Director was appointed as a Director on 29 Mar 2013 & has been associated with this company since 12 years 8 months . was documented.
Progress on Felix Reutter was appointed as a Director was appointed as a Director on 29 Mar 2013 & has been associated with this company since 12 years 8 months . was documented.
Sham Shridhar Nikam was appointed as a Director was appointed as a Director on 29 Mar 2013 & has been associated with this company since 12 years 8 months . was recorded as a recent event.
The activity Nycomed Pharma Private Limited was registered on 09 May 2003 with Roc Mumbai & aged 22 years 6 months as per MCA records. was completed.
The CIN of Nycomed Pharma Private Limited is U24239MH2003PTC148545.
Nycomed Pharma Private Limited is headquartered at 2/E Court Chambers 2Nd Floor,35, New Marine Lines, Mumbai, Maharashtra, 400020.
Nycomed Pharma Private Limited was incorporated on 09 May 2003.
The current directors of Nycomed Pharma Private Limited are
The primary industry of Nycomed Pharma Private Limited is Pharma.
Nycomed Pharma Private Limited is unlisted.
The authorized capital of Nycomed Pharma Private Limited is ₹50.00 Cr, and the paid-up capital is ₹9.72 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX